메뉴 건너뛰기




Volumn 129, Issue 7, 2009, Pages 632-633

Tobakksrøyking og interaksjoner med legemidler

(2)  Molden, Espen a   Spigset, Olav a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; DRUG; GLUCURONOSYLTRANSFERASE;

EID: 63649104003     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.08.0122     Document Type: Article
Times cited : (5)

References (11)
  • 2
    • 0034958715 scopus 로고    scopus 로고
    • Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective
    • Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs 2001; 15: 469-94.
    • (2001) CNS Drugs , vol.15 , pp. 469-494
    • Desai, H.D.1    Seabolt, J.2    Jann, M.W.3
  • 3
    • 34548806494 scopus 로고    scopus 로고
    • Drug interactions with smoking
    • Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm 2007; 64: 1917-21.
    • (2007) Am J Health Syst Pharm , vol.64 , pp. 1917-1921
    • Kroon, L.A.1
  • 4
    • 15244342411 scopus 로고    scopus 로고
    • UDP-glucuronosyltransferases and clinical drug-drug interactions
    • Kiang TK, Ensom MH, Chang TK. UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 2005; 106: 97-132.
    • (2005) Pharmacol Ther , vol.106 , pp. 97-132
    • Kiang, T.K.1    Ensom, M.H.2    Chang, T.K.3
  • 5
    • 0032805239 scopus 로고    scopus 로고
    • Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test
    • Tantcheva-Poor I, Zaigler M, Rietbrock S et al. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 1999; 9: 131-44.
    • (1999) Pharmacogenetics , vol.9 , pp. 131-144
    • Tantcheva-Poor, I.1    Zaigler, M.2    Rietbrock, S.3
  • 6
    • 33751252806 scopus 로고    scopus 로고
    • The effect of variable cigarette consumption on the interaction with clozapine and olanzapine
    • Haslemo T, Eikeseth PH, Tanum L et al. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine. Eur J Clin Pharmacol 2006; 62: 1049-53.
    • (2006) Eur J Clin Pharmacol , vol.62 , pp. 1049-1053
    • Haslemo, T.1    Eikeseth, P.H.2    Tanum, L.3
  • 7
    • 3543019165 scopus 로고    scopus 로고
    • Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
    • Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther 2004; 76: 178-84.
    • (2004) Clin Pharmacol Ther , vol.76 , pp. 178-184
    • Faber, M.S.1    Fuhr, U.2
  • 8
    • 0036238160 scopus 로고    scopus 로고
    • Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine
    • Zullino DF, Delessert D, Eap CB et al. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol 2002; 17: 141-3.
    • (2002) Int Clin Psychopharmacol , vol.17 , pp. 141-143
    • Zullino, D.F.1    Delessert, D.2    Eap, C.B.3
  • 9
    • 26844507816 scopus 로고    scopus 로고
    • Clozapine toxicity associated with smoking cessation: case report
    • Derenne JL, Baldessarini RJ. Clozapine toxicity associated with smoking cessation: case report. Am J Ther 2005; 12: 469-71.
    • (2005) Am J Ther , vol.12 , pp. 469-471
    • Derenne, J.L.1    Baldessarini, R.J.2
  • 10
    • 0028026791 scopus 로고
    • Seizures following smoking cessation in a clozapine responder
    • McCarthy RH. Seizures following smoking cessation in a clozapine responder. Pharmacopsychiatry 1994; 27: 210-1.
    • (1994) Pharmacopsychiatry , vol.27 , pp. 210-211
    • McCarthy, R.H.1
  • 11
    • 0032851490 scopus 로고    scopus 로고
    • Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report
    • Skogh E, Bengtsson F, Nordin C. Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report. Ther Drug Monit 1999; 21: 580-2.
    • (1999) Ther Drug Monit , vol.21 , pp. 580-582
    • Skogh, E.1    Bengtsson, F.2    Nordin, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.